Allworth Financial’s FibroBiologics FBLG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17 Hold
13
– – ﹤0.01% 5372
2026
Q2
$13 Hold
13
– – ﹤0.01% 5119
2026
Q1
$18 Hold
13
– – ﹤0.01% 5139
2025
Q4
$59 Hold
13
– – ﹤0.01% 4830
2025
Q3
$143 Hold
13
– – ﹤0.01% 4640
2025
Q2
$163 Hold
13
– – ﹤0.01% 4344
2025
Q1
$337 Hold
13
– – ﹤0.01% 3774
2024
Q4
$441 Hold
13
– – ﹤0.01% 3636
2024
Q3
$806 Hold
13
– – ﹤0.01% 3296
2024
Q2
$1.17K Hold
13
– – ﹤0.01% 3113
2024
Q1
$2.82K Buy
+13
New +$3.12K ﹤0.01% 2675

Other funds holding FBLG

Allworth Financial's FBLG Position: Q3 2026 in Review

Allworth Financial held its FibroBiologics (FBLG) position steady in Q3 2026 at 13 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #5372.

Allworth Financial first reported a position in FBLG in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.82K in Q1 2024. 19 funds tracked by Wall St. Rank hold FBLG as of Q3 2026.

  • Allworth Financial held 13 shares of FibroBiologics worth $17 as of Q3 2026.
  • Allworth Financial left its FibroBiologics share count unchanged in Q3 2026.
  • FibroBiologics made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #5372 holding.
  • Allworth Financial first reported a position in FibroBiologics in Q1 2024 and has held it in 11 quarters since.
  • Allworth Financial's FibroBiologics position peaked at $2.82K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held FibroBiologics as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.